Translumina Therapeutics LLP vs PCIT
In this landmark ruling, the Income Tax Appellate Tribunal, Delhi Bench, overturned the Commissioner’s revision under section 263, reinforcing that mere disagreement with the Assessing Officer’s enquiry does not warrant revision if the officer applied his mind. The Tribunal meticulously validated the jurisdictional transfer from New Delhi to Dehradun, upholding the assessment’s procedural integrity. Crucially, it emphasized that the Assessing Officer’s comprehensive scrutiny—including audit reports, third-party verifications, and technical evaluations—sufficed to justify the deduction under section 80IC for manufacturing drug-eluting stents. The decision curtails arbitrary use of revisionary powers, affirming that ‘erroneous’ orders must stem from tangible lapses, not perceived inadequacies. For professionals, this judgment underscores the importance of documented enquiries and the prospective nature of Explanation 2 to section 263, offering a robust defense against revisionary overreach in deduction claims.
Translumina Therapeutics LLP vs PCIT View Full Article »
